Muna Therapeutics
PrivateLast Round
Grant
Jan 8, 2026
Total Funding Raised
$113.9M
Company Overview
Muna Therapeutics is a biopharmaceutical company that discovers and develops small-molecule therapeutics aimed at slowing or halting the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Muna Therapeutics Comparables
Compare Muna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AstronauTx | 86% | |
| Vanqua Bio | 81% | |
| Cajal Neuroscience | 81% | |
Muna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 8, 2026 | ||||
| Strategic | Dec 5, 2024 | ||||
| Series B | Oct 17, 2023 | ||||
| Grant | Oct 11, 2022 | ||||
| Series A | Jul 9, 2021 |
Muna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series A |
| LF Investments | Series A |
| AXXAM Family Office | Series A |
| Droia Ventures | Seed, Series A |
| V-Bio Ventures | Series A |
| Novo Holdings | Seed, Series A |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 266% MoM, reaching 18.9K.
- Oct 11, 2022
$5M grant from The Michael J. Fox Foundation.
Muna Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Muna Therapeutics's valuation, stock price, and market status.